A Biomimetic Copper‐Caffeic Acid Nanozyme Activates Cuproptosis and Pyroptosis by Mimicking the Neutrophil Enzymatic Cascade
Advanced Healthcare Materials · 2026-07 · 15 (28)
DOI: 10.1002/adhm.202505342 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 02.07.2026. Verfasst von Yangyang Lu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The Affiliated Hospital of Qingdao University, Qingdao, China. Hauptthemen laut MEDLINE: Cuproptosis, Copper, Neutrophils, Biomimetic Materials. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Jiangxi Provincial Natural Science Foundation, Shandong Provincial Natural Science Foundation, WU JIEPING MEDICAL FOUNDATION.
Abstract (Originalsprache)
Neutrophils combat tumors through a distinct enzymatic cascade involving superoxide dismutase (SOD) and myeloperoxidase (MPO), a biocatalytic mechanism that offers a promising platform for novel antitumor strategies. However, the clinical translation of natural enzymes is hindered by inherent limitations, including poor stability and high immunogenicity. In this context, nanozymes have emerged as advanced tools for tumor therapy, with the development of cascade catalytic nanosystems representing a major research frontier. This study designed multifunctional copper‐caffeic acid metal‐phenolic networks (Cu‐CA MPNs). Upon lysosomal entry, the nanozyme mimics the neutrophil's SOD‐MPO cascade to continuously generate substantial reactive oxygen species (ROS), notably hypochlorous acid (HOCl). This process directly damages lysosomes, promotes mitochondrial ROS accumulation, and upregulates the expression of GSDMD‐N and GSDME‐N, ultimately triggering pyroptosis. Simultaneously, Cu‐CA MPNs released from ruptured lysosomes cause abnormal copper ion accumulation within mitochondria. This enhances oligomerization of the DLAT protein and downregulates key metabolic proteins‐including ACO2, ETFDH, LIAS, and FDX1‐thereby inducing cuproptosis. In a tumor‐bearing mouse model, Cu‐CA MPNs demonstrated potent antitumor efficacy and favorable biosafety. This work provides a new perspective for tumor catalytic therapy using nanozymes that simulate the neutrophil enzymatic cascade.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, The Affiliated Hospital of Qingdao University, Qingdao, China.
- School of Basic Medical Sciences, Yichun University, Yichun, China.
ORCID-Profile: Weiwei Qi
Förderung
- Jiangxi Provincial Natural Science Foundation
- Shandong Provincial Natural Science Foundation
- WU JIEPING MEDICAL FOUNDATION
- Qingdao Huimin Technology
- China zhongguancun Precision Medicine science and technology foundation
- The Affiliated Hospital of Qingdao University "Clinical Medicine + X" Research Program
- Natural Science Foundation of Shandong Province
Zitieren
APA
Lu, Y., Li, Y., Yan, H., Sun, X., Li, X., Fang, Y., Zhang, S., Tian, J., Wang, X., Luo, C., Qiu, W., & Qi, W. (2026). A Biomimetic Copper‐Caffeic Acid Nanozyme Activates Cuproptosis and Pyroptosis by Mimicking the Neutrophil Enzymatic Cascade. Advanced Healthcare Materials, 15(28). https://doi.org/10.1002/adhm.202505342
Vancouver
Lu Y, Li Y, Yan H, Sun X, Li X, Fang Y, et al. A Biomimetic Copper‐Caffeic Acid Nanozyme Activates Cuproptosis and Pyroptosis by Mimicking the Neutrophil Enzymatic Cascade. Advanced Healthcare Materials. 2026;15(28). doi:10.1002/adhm.202505342
BibTeX
@article{Lu2026,
author = {Lu, Yangyang and Li, Yan and Yan, Hongyang and Sun, Xueying and Li, Xin and Fang, Yuanyuan and Zhang, Siyi and Tian, Jingwen and Wang, Xin and Luo, Cheng and Qiu, Wensheng and Qi, Weiwei},
title = {A Biomimetic Copper‐Caffeic Acid Nanozyme Activates Cuproptosis and Pyroptosis by Mimicking the Neutrophil Enzymatic Cascade},
journal = {Advanced Healthcare Materials},
year = {2026},
volume = {15},
number = {28},
doi = {10.1002/adhm.202505342}
}
EUVIMED